Comparison of Mood Disorders Screening Scales in Geriatric Oncology

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the scales commonly used in geriatrics and oncology distress thermometer ( analogue scale rated from 0 to 1 for the emotional distress ) , the GDS15 (15 issues closed binary response seeking signs of depression ) the HADS (14 questions assessing the intensity of anxiety signs and signs of depression listed 0-3 ).

The prospective observational study will be conducted in parallel on two sites ( University Hospital Centre and François Baclesse ) after informed patient information.

It will be offered to patients 70 years and over with a new diagnosis or relapse of cancer or haematological malignancies in the hospital to meet the mood disorder screening questionnaires .

Clinical Trial Description

There are various tools validated and recommended by the SiO and SFPO for screening mood disorders in geriatric oncology . The choice among them depends on the usual practices of the various teams , only some scales assessing depressive signs and other signs of anxiety too. None were assessed in a population aged diagnosis of cancer or hematologic malignancy in pre- therapeutic situation.

The objective of this study is to evaluate the scales commonly used in geriatrics and oncology distress thermometer ( analogue scale rated from 0 to 1 for the emotional distress ) , the GDS15 (15 issues closed binary response seeking signs of depression ) the HADS (14 questions assessing the intensity of anxiety signs and signs of depression listed 0-3 ) The prospective observational study will be conducted in parallel on two sites ( University Hospital Centre and François Baclesse ) after informed patient information.

It will be offered to patients 70 years and over with a new diagnosis or relapse of cancer or haematological malignancies in the hospital to meet the mood disorder screening questionnaires .

If one test is abnormal , a clinical psychological care will be offered . When returning home : telephone contact will be made the same day with the doctor , asking him to please make thymic revaluation within 2 weeks ( informed patient). It will be sent to the doctor by post a rubric of Major Depressive Episode criteria of the DSM V to return . If the patient remains hospitalized , the doctor taking care of patient will be contacted to obtain the same information .

In addition, the investigators will study the impact on the management (change or introduction of an antidepressant and / or anxiolytic use of psychotherapy or psychological counseling ... ) to 5 weeks ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02799524
Study type	Observational
Source	University Hospital, Caen
Contact
Status	Completed
Phase	N/A
Start date	December 2015
Completion date	July 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05321602` - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder	Phase 1
Recruiting	`NCT05345392` - Brain, Emotions, and Mind-Wandering	N/A
Completed	`NCT05078450` - Mood Lifters Online for Graduate Students and Young Professionals	N/A
Not yet recruiting	`NCT04551027` - Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness	N/A
Recruiting	`NCT03088657` - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
Active, not recruiting	`NCT02542475` - Low Field Magnetic Stimulation: Open Label Study.	Phase 1/Phase 2
Completed	`NCT00916552` - Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder	Phase 2
Completed	`NCT00202514` - Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms	Phase 2/Phase 3
Completed	`NCT00217932` - Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings	Phase 2
Completed	`NCT00006517` - Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)	N/A
Terminated	`NCT03898843` - Assisted Animal Therapy: ReAnimal	N/A
Active, not recruiting	`NCT04358900` - Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Recruiting	`NCT06360562` - Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)	N/A
Completed	`NCT05745103` - Optimizing Behavioral Healthcare Delivery Through Technology	N/A
Suspended	`NCT03715400` - Mobile Virtual Positive Experiences for Anhedonia	N/A
Enrolling by invitation	`NCT03736538` - Nitrous Oxide- Suicidal Ideation	Phase 1
Completed	`NCT04601545` - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method	N/A
Completed	`NCT02566980` - Biological Triggers of Depression in Pregnancy
Completed	`NCT03743844` - Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity	N/A
Completed	`NCT05211063` - Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Mood Disorders Screening Scales in Geriatric Oncology — Thymog

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms